Three decades of P-gp inhibitors: skimming through several generations and scaffolds

A Palmeira, E Sousa, MH Vasconcelos… - Current medicinal …, 2012 - ingentaconnect.com
Many tumor cells become resistant to commonly used cytotoxic drugs due to the
overexpression of ATP-binding cassette (ABC) transporters, namely P-glycoprotein (P-gp) …

P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives

Z Binkhathlan, A Lavasanifar - Current cancer drug targets, 2013 - ingentaconnect.com
One of the major causes of failure in cancer chemotherapy is multidrug resistance (MDR),
where cancer cells simultaneously become resistant to different anticancer drugs. Over …

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs

K Kuroda, K Okumura, H Isogai, E Isogai - Frontiers in oncology, 2015 - frontiersin.org
Antimicrobial peptides (AMPs) play a critical role in innate host defense against microbial
pathogens in many organisms. The human cathelicidin, LL-37, has a net positive charge …

Endothelin receptor antagonists: status quo and future perspectives for targeted therapy

FC Enevoldsen, J Sahana, M Wehland… - Journal of clinical …, 2020 - mdpi.com
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …

On the selectivity and efficacy of defense peptides with respect to cancer cells

F Harris, SR Dennison, J Singh… - Medicinal research …, 2013 - Wiley Online Library
Here, we review potential determinants of the anticancer efficacy of innate immune peptides
(ACPs) for cancer cells. These determinants include membrane‐based factors, such as …

Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?

C Disoma, Y Zhou, S Li, J Peng, Z Xia - Biochimie, 2022 - Elsevier
The Wnt/β-catenin signaling pathway has been implicated as the central mechanism that
drives colorectal carcinogenesis. Its activation is historically due to mutation on APC …

Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells

X Ma, Y Cai, D He, C Zou, P Zhang… - Proceedings of the …, 2012 - National Acad Sciences
An attractive strategy to overcome multidrug resistance in cancer chemotherapy is to
suppress P-glycoprotein (P-gp), which is a pump overproduced in cancer cells to remove …

Let‐7 modulates acquired resistance of ovarian cancer to Taxanes via IMP‐1‐mediated stabilization of multidrug resistance 1

B Boyerinas, SM Park, AE Murmann… - … journal of cancer, 2012 - Wiley Online Library
Ovarian cancer patients frequently develop resistance to chemotherapy regiments using
Taxol and carboplatin. One of the resistance factors that protects cancer cells from Taxol …

Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer.

Z Chen, Y Li, B Tan, Q Zhao, L Fan, F Li… - Drugs of today …, 2020 - europepmc.org
Gastric cancer is one of the most common malignant tumors in the world. In China, its
morbidity and mortality are second only to lung cancer. Chemotherapy combined with …

[图书][B] Antimicrobial peptides

DA Phoenix, SR Dennison, F Harris - 2012 - books.google.com
In this text, the small team of expert authors presents the field in a comprehensive and
accessible manner that is well suited for students and junior researchers. The result is a …